Ovid Therapeutics Inc.

New Filing
CIK: 0001636651·Other Health Care·DELAWARE·Filed: Jan 20, 2017
Total Offering

$25,861,228

Amount Sold

$25,861,228

Investors

1

First Sale

Jan 6, 2017

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2014
Non-Accredited Investors
No

Related Persons

NameRole
Matthew J. During
Related Person
Jeremy M. Levin
Related Person
Yaron Werber
Related Person
Bart Friedman
Related Person
Douglas E. Williams
Related Person
Karen Bernstein
Related Person
Amit Rakhit
Related Person

Company

Ovid Therapeutics Inc.

1460 Broadway

New York, NY, 10036

646-661-7661

SEC Filing

0001636651-17-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Ovid Therapeutics Inc. Form D Filing — $25,861,228 | FilingFlow